Datasheet

生物学的記述

Specificity	Phospho-Tyrosine Antibody [N16H13] detects a broad range of tyrosine-phosphorylated proteins and peptides.
Background	Phospho-tyrosine represents the O‑phosphorylated form of the amino acid tyrosine within proteins and functions as a central modular signal in eukaryotic regulatory networks, where its reversible formation and recognition by dedicated domains control many aspects of cell communication, growth, and differentiation. The modification resides on the phenolic hydroxyl of tyrosine in protein side chains and is generated and removed by a tripartite toolkit of protein tyrosine kinases and protein tyrosine phosphatases together with Src homology 2 and related phosphotyrosine-binding domains that read phospho-tyrosine motifs and assemble signaling complexes; this architecture forms a highly interconnected, combinatorial code that enables specific cellular responses to extracellular cues. Tyrosine phosphorylation in receptor and nonreceptor tyrosine kinases creates docking sites for SH2- and PTB-domain-containing adaptors and enzymes and thereby couples ligand-induced receptor activation to downstream cascades such as RAS–RAF–MEK–ERK, PI3K–AKT, JAK–STAT, and PLCγ–Ca²⁺ signaling, allowing phospho-tyrosine patterns on receptors and scaffolds to define pathway selection and signal amplitude. Large-scale analyses of human phospho-tyrosine networks show that sets of phospho-tyrosine motifs and SH2-domain specificities form interlinked protein clusters at activated receptors and within cytoplasmic signaling hubs, and conditional phospho-tyrosine–dependent interactions create pathway branching and feedback loops that coordinate receptor trafficking, cytoskeletal remodeling, transcriptional activation, and metabolic adaptation. The abundance and distribution of phospho-tyrosine sites are tightly controlled by the balance between kinases and classical protein tyrosine phosphatases, whose catalytic domains are highly selective for phospho-tyrosine and terminate or reshape signaling by dephosphorylating receptors, intermediates, and transcription factors. Alterations in this balance lead to persistent or defective signal propagation. Comparative genomic and evolutionary analyses indicate that the full phospho-tyrosine toolkit expanded markedly at the origin of multicellular animals, with coordinated increases in tyrosine kinases, phosphatases, and SH2-domain proteins that correlate with more complex cell–cell and cell–matrix communication, highlighting phospho-tyrosine as a key innovation for metazoan signaling complexity. Dysregulation of phospho-tyrosine signaling through mutations, overexpression, or aberrant activation of tyrosine kinases, and loss or misregulation of phosphatases, is a hallmark of many cancers, immune disorders, and metabolic diseases, in which altered phospho-tyrosine landscapes drive oncogenic signaling, resistance to apoptosis, aberrant immune activation, or impaired insulin and leptin responses.

Specificity

Phospho-Tyrosine Antibody [N16H13] detects a broad range of tyrosine-phosphorylated proteins and peptides.

Background

Phospho-tyrosine represents the O‑phosphorylated form of the amino acid tyrosine within proteins and functions as a central modular signal in eukaryotic regulatory networks, where its reversible formation and recognition by dedicated domains control many aspects of cell communication, growth, and differentiation. The modification resides on the phenolic hydroxyl of tyrosine in protein side chains and is generated and removed by a tripartite toolkit of protein tyrosine kinases and protein tyrosine phosphatases together with Src homology 2 and related phosphotyrosine-binding domains that read phospho-tyrosine motifs and assemble signaling complexes; this architecture forms a highly interconnected, combinatorial code that enables specific cellular responses to extracellular cues. Tyrosine phosphorylation in receptor and nonreceptor tyrosine kinases creates docking sites for SH2- and PTB-domain-containing adaptors and enzymes and thereby couples ligand-induced receptor activation to downstream cascades such as RAS–RAF–MEK–ERK, PI3K–AKT, JAK–STAT, and PLCγ–Ca²⁺ signaling, allowing phospho-tyrosine patterns on receptors and scaffolds to define pathway selection and signal amplitude. Large-scale analyses of human phospho-tyrosine networks show that sets of phospho-tyrosine motifs and SH2-domain specificities form interlinked protein clusters at activated receptors and within cytoplasmic signaling hubs, and conditional phospho-tyrosine–dependent interactions create pathway branching and feedback loops that coordinate receptor trafficking, cytoskeletal remodeling, transcriptional activation, and metabolic adaptation. The abundance and distribution of phospho-tyrosine sites are tightly controlled by the balance between kinases and classical protein tyrosine phosphatases, whose catalytic domains are highly selective for phospho-tyrosine and terminate or reshape signaling by dephosphorylating receptors, intermediates, and transcription factors. Alterations in this balance lead to persistent or defective signal propagation. Comparative genomic and evolutionary analyses indicate that the full phospho-tyrosine toolkit expanded markedly at the origin of multicellular animals, with coordinated increases in tyrosine kinases, phosphatases, and SH2-domain proteins that correlate with more complex cell–cell and cell–matrix communication, highlighting phospho-tyrosine as a key innovation for metazoan signaling complexity. Dysregulation of phospho-tyrosine signaling through mutations, overexpression, or aberrant activation of tyrosine kinases, and loss or misregulation of phosphatases, is a hallmark of many cancers, immune disorders, and metabolic diseases, in which altered phospho-tyrosine landscapes drive oncogenic signaling, resistance to apoptosis, aberrant immune activation, or impaired insulin and leptin responses.

使用情報

Application

WB

Dilution

WB	IP	IHC	IF	FCM
1:2000	1:100	1:2400 - 1:9600	1:1600 - 1:3200	1:1600 - 1:6400

Reactivity

All Species Expected

Source

Mouse Monoclonal Antibody

MW

Storage Buffer

PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3

Storage
(from the date of receipt)

-20°C (avoid freeze-thaw cycles), 2 years

プロトコール

References

https://pubmed.ncbi.nlm.nih.gov/22194470/
https://pubmed.ncbi.nlm.nih.gov/20813250/

Phospho-Tyrosine Antibody [N16H13]

生物学的記述

使用情報

References

Application Data